Iridium-Catalyzed Asymmetric Hydrogenation of 3-Substituted 2H-1,4-Benzoxazines
文献类型:期刊论文
作者 | Gao, Kai1; Yu, Chang-Bin1; Wang, Duo-Sheng1; Zhou, Yong-Gui1,2 |
刊名 | advanced synthesis & catalysis
![]() |
出版日期 | 2012-02-01 |
卷号 | 354期号:2-3页码:483-488 |
关键词 | asymmetric hydrogenation benzoxazines chiral amines cyclic imines iridium |
英文摘要 | the highly enantioselective hydrogenation of 3-aryl-2h-1,4-benzoxazines was achieved using the (cyclooctadiene)iridium chloride dimer/(s)-segphos/iodine {[ir(cod)cl]2/(s)-segphos/i2} system as catalyst with up to 92% ee. the 3-styryl-2h-1,4-benzoxazine derivatives were also hydrogenated by the iridium catalyst and pd/c in two consecutive steps whereby 9395% ee values were obtained. |
WOS标题词 | science & technology ; physical sciences |
类目[WOS] | chemistry, applied ; chemistry, organic |
研究领域[WOS] | chemistry |
关键词[WOS] | highly enantioselective hydrogenation ; n-aryl imines ; kinetic resolution ; heteroaromatic-compounds ; reductive amination ; key intermediate ; acyclic imines ; cyclic imines ; complexes ; quinolines |
收录类别 | SCI ; IC |
语种 | 英语 |
WOS记录号 | WOS:000300448400029 |
公开日期 | 2015-11-17 |
源URL | [http://159.226.238.44/handle/321008/143097] ![]() |
专题 | 大连化学物理研究所_中国科学院大连化学物理研究所 |
作者单位 | 1.Chinese Acad Sci, State Key Lab Catalysis, Dalian Inst Chem Phys, Dalian 116023, Peoples R China 2.Chinese Acad Sci, State Key Lab Organometall Chem, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China |
推荐引用方式 GB/T 7714 | Gao, Kai,Yu, Chang-Bin,Wang, Duo-Sheng,et al. Iridium-Catalyzed Asymmetric Hydrogenation of 3-Substituted 2H-1,4-Benzoxazines[J]. advanced synthesis & catalysis,2012,354(2-3):483-488. |
APA | Gao, Kai,Yu, Chang-Bin,Wang, Duo-Sheng,&Zhou, Yong-Gui.(2012).Iridium-Catalyzed Asymmetric Hydrogenation of 3-Substituted 2H-1,4-Benzoxazines.advanced synthesis & catalysis,354(2-3),483-488. |
MLA | Gao, Kai,et al."Iridium-Catalyzed Asymmetric Hydrogenation of 3-Substituted 2H-1,4-Benzoxazines".advanced synthesis & catalysis 354.2-3(2012):483-488. |
入库方式: OAI收割
来源:大连化学物理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。